Conba Group’s subsidiary Zhejiang Conba Pharmaceutical has completed the sale of 57.3% stake in a pharmaceutical company.
Zhejiang Conba has received a consideration of ¥345.1m ($50.27m) from the stake sale.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Based in China, Zhejiang Conba Pharmaceutical sells medicines and chemical products.
Chabiotech subsidiary CHA Healthcare has reached an agreement to acquire 8.8% stake in Singapore Medical Group.
The stake represents 30 million shares of the target company and costs KRW12.07bn ($10.23m) for the acquirer company.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
